Abstract #0847
Utility of combined Ga-68 DOTA-TOC PET and Eovist MRI utilizing PET/MRI
Thomas A Hope 1 , Carina Mari Aparici 1 , Eric Nakakura 2 , Henry VanBrocklin 1 , Miguel Hernandez Pampaloni 1 , James Slater 1 , Salma Jivan 1 , Judy Yee 1 , and Emily Bergsland 3
1
Radiology and Biomedical Imaging, UCSF, San
Francisco, CA, United States,
2
Department
of Surgery, UCSF, San Francisco, CA, United States,
3
Department
of Medicine, UCSF, San Francisco, CA, United States
We have evaluated the combined modality PET/MRI for
imaging of patients with hepatic metastasis from
neuroendocrine tumor. Patients were imaged using Ga-68
labeled DOTA-TOC in conjuction with gadoxetate disodium
as an MR contrast agent. Preliminary data demonstrates
that PET/MRI is at least equivalent to PET/CT, with
likely improved detection of hepatic lesions on
hepatobiliary phase imaging.
This abstract and the presentation materials are available to members only;
a login is required.
Join Here
